Compound library / Hormones & fertility / Hormone Replacement

HGH (Somatropin)

Recombinant human growth hormone, FDA-approved for diagnosed GH deficiency and several other specific conditions; also a 191-amino-acid peptide hormone, unlike testosterone.

CategoryHormone Replacement
Regulatory standingApproved medicine
Typical routeSubcutaneous
Half-life~2-4 hours (serum); biological effects last much longer
Common dose range1-4 IU/day (varies enormously by indication and goal)
Typical cycle lengthOngoing under medical supervision

BioHack Track models HGH (Somatropin) at a half-life of 3 hours, so every dose you log is decayed against that curve and the app shows estimated active levels — not just what you typed.

Approved medicine

An FDA-approved product containing this compound exists, and its label is linked under Primary sources below. That label is the authority on dosing; the range on this page describes what people commonly track, including off-label use, and does not replace it.

Reconstitution

Reconstitute with provided diluent or bacteriostatic water; swirl gently, don't shake.

Storage

Refrigerate; protect from light. Some pens stable briefly at room temp per label.

Cautions

Prescription medication requiring diagnosis and monitoring (IGF-1, glucose, thyroid). Non-prescribed use carries risks including insulin resistance, joint/soft-tissue swelling, and unknown long-term effects at performance doses.

Track HGH (Somatropin) in BioHack Track. Half-life, dose range and route come pre-filled from this library — log a dose and the app counts your vial down, models what is in your system, and puts it on the same chart as your labs and body composition.

Others in Hormone Replacement

What the evidence says

Evidence Check asks 10 questions about every compound. For HGH (Somatropin) it can answer 1 of them, from the papers we hold — graded by how strong the study design is, not by whether the findings are flattering. These are the same verdicts the app gives.

Some Clinical EvidenceSleep

Clinical trials in humans have looked at this.

  • [Action of growth hormone releasing hormone (GHRH) on sleep EEG and nocturnal secretion of growth hormone, cortisol and ACTH in patients with major depression]Randomized Controlled Trial · Wien Med Wochenschr · 1995 · PMID 8588384
  • [Liberation of growth hormone and melanocyte-stimulating hormone in natural and melatonin-induced human sleep (author's transl)]Randomized Controlled Trial · Arzneimittelforschung · 1976 · PMID 989378

Look up the research

These open a search of each database for HGH (Somatropin) — they are not citations, and nothing here is evidence for any particular dose. The same links are in the app.

Work it out

Selected published studies

12 papers naming HGH (Somatropin) in the title, drawn from PubMed and limited to reviews, meta-analyses and trials. Each was checked against PubMed’s own record for its title, journal and year. This is a starting point, not an evidence review — nothing here is offered as support for the dose range above, and the list is not exhaustive. See the editorial policy.

Where these figures come from

The half-life, route and dose range on this page are compiled from published pharmacokinetic literature, manufacturer and product monographs where one exists, and the ranges commonly reported in clinical and research use. They are kept as a range rather than a single figure because that is what the sources actually support — a half-life varies with route, formulation and the person.

These are not citations, and this page is not a review of the evidence. Where a number matters to you, follow the database links above and read the source. We say so plainly rather than dressing a compiled reference up as one.

Nothing on this page has been reviewed by a named clinician. It is a reference for people already tracking a protocol, not a recommendation to start one.

Published by Creative Images LLC · Last updated · Corrections: support